The Roadmap Initiative to Good Lay Summary Practice
Over 60 participants from EU and US pharmaceutical companies, CROs, academic institutions, patient organisations, and not-for-profit organisations have formed the “Roadmap Initiative to Good Lay Summary Practice” with the aim to develop and implement a pragmatic, broadly accepted framework for Lay Summary planning, development, translation, and dissemination.
GLSP for Patients and Researchers
More information in Lay Language about GLSP
The GLSP in different languagesRoadmap Initiative Updates
Get our updates by email now, register to our Newsletter.
Newsletter Registration[Article] from March EMWA Vol.
Lay titles for clinical trials: Is industry achieving the balance?by AMWA Journal | March 2023
View
[Interview] The Making of GLSP
Interview of Dr. Klingmann by the AMWA Journal - PDF Documentby AMWA Journal | 13 June 2022
View
[Workshop Report] Implementing Good Lay Summary Practice
Date: 14, 15 & 21 Febryary 2022 | Workshop Report Availableby GLSP Core Team | 21 April 2022
View